Epstein Secrets

. The AP <https://www.usatoday.com/story/money/2020/10/22/us-stocks-flip-flop-amid-profit-reports-stimulus- talks/3727449001/> (10/22, Choe, Troise, Veiga) and the Wall Street Journal <https://www.wsj.com/articles/global-stock-markets-dow-update-10-22-2020-11603358278> (10/22, Bartholomew, Eisen, Subs

reuters.com/article/us-health-coronavirus-gilead/gileads-remdesivir-gets-u-s-fda-approval- for-hospitalized-covid-19-patients-idUSICBN2772XQ> (10/22, Beasley) reports that despite positive results from NIH and the new approval, "the World Health Organization (WHO) last week said its global trial of COVID-

er at 28,363.66, the S&P 500 added 17.93 points to close at 3,453.49, and the Nasdaq climbed 21.31 points to 11,506.01. The AP (10/22, Choe, Troise, Veiga) and the Wall Street Journal (10/22, Bartholomew, Eisen, Subscription Publication, 7.57M), and Bloomberg (10/22, Haigh, 4.73M) provide similar cover

though the FDA "will still allow the drug's use in certain cases under its previous emergency authorization" for patients under 12. Reuters (10/22, Beasley) reports that despite positive results from NIH and the new approval, "the World Health Organization (WHO) last week said its global trial of COVID-

er at 28,363.66, the S&P 500 added 17.93 points to close at 3,453.49, and the Nasdaq climbed 21.31 points to 11,506.01. The AR (10/22, Choe, Troise, Veiga) and the Wall Street Journal (10/22, Bartholomew, Eisen, Subscription Publication, 7.57M), and Bloomberg (10/22, Haigh, 4.73M) provide similar cove

ough the FDA "will still allow the drug's use in certain cases under its previous emergency authorization" for patients under 12. Retiterc (10/22, Beasley) reports that despite positive results from NIH and the new approval, "the World Health Organization (WHO) last week said its global trial of COVID-